Clinical Trial Update: Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluate safety and efficacy of S-707106 in adults with type 2 diabetes mellitus not adequately controlled by metformin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• S-707106

Snippet

Sponsor: Shionogi | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED